Home  /  Resource Library  /  Early Complete Responses with Mosunetuzumab Monotherapy in Treatment-Naive Follicular and Marginal Zone Lymphomas with Only Low-Grade Cytokine Release Syndrome

Early Complete Responses with Mosunetuzumab Monotherapy in Treatment-Naive Follicular and Marginal Zone Lymphomas with Only Low-Grade Cytokine Release Syndrome

ASH 2023